Related by context. All words. (Click for frequent words.) 83 AQD class 78 Voreloxin 72 oral nucleoside analogue 72 2 methoxyestradiol 72 Alfacell proprietary ribonuclease 71 non nucleoside inhibitor 71 orally administered inhibitor 71 XL# anticancer compounds 71 PNP inhibitor 71 allosteric modulator NAM 70 Completes Patient Enrollment 70 generation Hsp# inhibitor 70 AAG geldanamycin analog 69 hormone LHRH antagonist 69 vinca alkaloid 69 Omacetaxine 69 dasatinib Sprycel ® 69 Initiates Phase II 69 novel topoisomerase 69 small molecule Hedgehog 69 IMiDs R 69 novel emulsion formulation 69 refractory chronic lymphocytic 69 developing Bicifadine serotonin 69 targeted radiotherapeutic 69 mGluR5 negative 69 Hsp# Inhibitor 69 IMiDs ® 69 both intercalates DNA 69 Albuferon TM 69 dextromethorphan quinidine 69 product candidate Lpathomab 69 pralatrexate injection folate analogue 68 agonistic human 68 cetuximab Erbitux R 68 Phase #b/#a clinical 68 Pegloticase 68 sodium glucose cotransporter 68 R roscovitine CDK cyclin 68 Cloretazine ® 68 peptidic compound 68 liposomal formulation 68 Pathway Inhibitor 68 Tezampanel 68 PEGylated Fab fragment 68 novel histone deacetylase 68 peripherally acting 68 anionic backbone 68 apoptosis inducer 68 candidates Azedra TM 68 mGluR2 positive 68 intravesical infusion therapy 68 Pruvel TM 68 dependent kinase inhibitor 68 oral isoform selective HDAC 68 TELINTRA R 68 Meets Primary Endpoint 68 topical gel formulation 68 PDX pralatrexate 68 vapreotide acetate 68 immunotherapeutic agent 68 MEK Inhibitor 68 Initiates Enrollment 68 antibody MAb 68 Initiate Phase 68 PEGylated anti 68 hyaluronidase enzyme 68 Viprovex ® 68 MTP inhibitor 67 CYP#A# CYP#D# 67 unique alkylating agent 67 R lenalidomide 67 CDK cyclin dependent 67 highly selective inhibitor 67 methylnaltrexone bromide 67 oral prodrug 67 HGS ETR1 mapatumumab 67 N acetylgalactosamine 6 67 Phase 2b Clinical Trial 67 Orally administered 67 IgG1 monoclonal antibody 67 MKC# MT 67 oral dihydropyrimidine dehydrogenase DPD 67 Lenocta TM 67 GVAX ® 67 Presents Positive 67 vinorelbine tartrate 67 VEGFR2 inhibitor 67 candidate deforolimus 67 cortisol synthesis 67 Oral Fingolimod 67 AEG# 67 Zenvia ™ 67 cutaneous T 67 hypoxia activated prodrug 67 siRNA binds 67 systemic anaplastic large 67 ALN PCS 67 INFeD R 67 Pivotal Phase III 67 investigational oral inhibitor 67 CYT# potent vascular disrupting 67 cyclophosphamide methotrexate 67 small molecule chemotherapeutic 67 LymphoStat B TM 67 Pruvel ™ 67 IMPDH inhibitor 67 MAGE A3 ASCI 67 MKC# MKC# PP 67 Orally Active 67 arsenic trioxide injection 67 alkylating agent 67 SPRYCEL ® 67 HCV RNA polymerase 67 2A receptor agonist 67 novel orally inhaled 67 Phase IIb Trial 67 therapeutically inactive prodrug 67 investigational humanized monoclonal antibody 67 alpha folate receptor 67 novel VDA molecule 67 highly purified pasteurized 67 proteasome inhibitor 67 ocular formulation 66 phase III isavuconazole 66 monoclonal antibody conjugated 66 Bortezomib 66 ALN HPN 66 Seliciclib 66 potent topoisomerase II 66 Cyclooxygenase Inhibiting Nitric Oxide 66 Randomized Phase 66 sapropterin dihydrochloride 66 Solazed TM 66 generation purine nucleoside 66 mGluR5 NAM 66 triggers apoptosis programmed 66 rxRNA 66 Xeloda ® 66 irinotecan doxorubicin oxaliplatin paclitaxel 66 accumulate preferentially 66 cell lymphoma CTCL 66 LymphoStat B belimumab 66 Initiates Phase III 66 Kinase Inhibitor 66 NASDAQ PPHM clinical 66 lintuzumab SGN 66 product platforms AZX# 66 myelofibrosis polycythemia vera 66 Safinamide 66 Personalized Immunotherapy 66 evaluating tivozanib 66 IL# PE#QQR 66 candidate AQ4N 66 Drug Candidate 66 Vitrasert R 66 approved incretin mimetic 66 PKC# 66 6R BH4 tetrahydrobiopterin naturally 66 alfa 2a 66 metaglidasen 66 Begins Dosing 66 HCV polymerase inhibitors 66 Presents Preclinical Data 66 Squalamine 66 4SC AG ISIN DE# 66 ATRA IV 66 developing Zerenex ferric 66 non porcine pancreatic 66 telomerase therapeutic 66 topoisomerase II inhibitor 66 FOLFOX6 chemotherapy regimen 66 lexidronam injection 66 familial amyloidotic polyneuropathy FAP 66 protein tyrosine phosphatase 1B 66 AKT inhibitor 66 Panzem R 66 Files IND 66 nucleoside analog 66 orally absorbed 66 Receives Orphan Drug Designation 66 5 FU leucovorin 66 novel immunomodulatory 66 evaluating picoplatin 66 XL# XL# 66 Aurora Kinase 66 Romidepsin 66 erlotinib Tarceva ® 66 OMP #R# 66 IMiDs ® compound 66 nilotinib Tasigna ® 66 leading oral taxane 66 selective serotonin 2C receptor 66 bevacizumab Avastin R 66 TKB# 66 molecular imaging radiopharmaceutical 66 treat chronic sinusitis 66 6 sulfatase 66 BUPHENYL R 66 Aztreonam lysine 66 IAP inhibitor 66 Initiates Clinical Trial 66 pan HDAC inhibitor 66 docetaxel Taxotere ® 66 Pivotal Phase 66 Completes Enrollment 66 Solzira TM 66 Study Evaluating 66 ® lenalidomide 66 induced macular edema 66 Temsirolimus 66 Commences Phase 66 XP# XP# 66 Peginterferon alfa 2b 66 TNF Tumor Necrosis Factor 66 RNAi Therapeutic 66 HDAC Inhibitor 66 Tesetaxel 66 modulator SERM 66 Granulocyte Colony Stimulating Factor 66 PRN FDA Approves 66 CORTOSS R 66 rusalatide acetate 66 ARRY # 66 NEBIDO R 66 Presents Preclinical 66 essential thrombocythemia ET 66 Novel Oral 65 CB2 selective receptor agonist 65 Granted Orphan Drug 65 virus HCV protease inhibitor 65 IAP inhibitors 65 Locteron exclusively 65 compound PMX # 65 ® bortezomib 65 initiated Phase Ib 65 drug pipeline TAFA# 65 nanofiltered plasma derived 65 dyskinesia PD LID 65 TAFA# 65 Bezielle 65 Dementia Related Psychosis 65 IMiD 65 Ecallantide 65 Randomized Double blind 65 delivered RNAi therapeutic 65 Tanespimycin 65 mocetinostat MGCD# 65 Zorbtive TM 65 Initiates Dosing 65 interferon gamma 1b 65 docetaxel Taxotere R 65 R Saizen R 65 TRIOLEX HE# APOPTONE HE# 65 GTC recombinant form 65 commercializing oxidized glutathione 65 histone deacetylase HDAC inhibitor 65 Nventa proprietary CoVal 65 SinuNase ™ 65 NUEDEXTA ™ 65 Investigational Oral 65 5 HT3 antagonist 65 candidate bevirimat PA 65 sapacitabine CYC# 65 development peramivir neuraminidase 65 mitogen activated ERK kinase 65 targeted antifolate 65 PDE4 inhibitor 65 trastuzumab Herceptin R 65 selective adhesion molecule 65 HSP# inhibitor 65 Agonist MABA program 65 myelodysplastic myeloproliferative diseases 65 injectable polymer 65 non nucleoside HCV 65 Panzem R NCD 65 combines bupropion 65 acyclovir Lauriad R 65 HCV NS5B polymerase 65 TM pralatrexate injection 65 novel tubulin binding 65 dihydrochloride Tablets 65 Quinamed R 65 Phase III Pivotal 65 generation PNP inhibitor 65 Genasense ® oblimersen 65 Intravenous Human 65 orally bioavailable 65 Seliciclib CYC# 65 selective A2A adenosine receptor 65 lead molecular radiotherapeutic 65 Receives Fast Track 65 Trial Evaluating 65 Ovitrelle R Serostim 65 Oracea TM 65 including eniluracil ADH 65 SinuNase TM 65 delivers fluocinolone acetonide FA 65 dual PPAR peroxisome 65 defensin mimetic antibiotic 65 oral ghrelin agonist 65 investigational pharmacologically unique 65 Vidaza ® 65 Iloperidone 65 Presents Positive Preclinical 65 PI3K/Akt pathway inhibitor 65 Submits NDA 65 Achieves Primary Endpoint 65 Pralatrexate 65 polymerase inhibitor 65 Ceflatonin R 65 somatostatin analog 65 candidate XP# 65 Empatic ™ 65 receptor tyrosine kinase inhibitor 65 INSPIRE Trial Phase III 65 allosteric modulator PAM 65 Shows Statistically Significant 65 Combination REOLYSIN R 65 Perifosine KRX 65 oral ferric iron 65 Receives Orphan Drug 65 influenza BCX# purine nucleoside 65 Phase IIb Clinical Trial 65 monoclonal antibody IgG1 Mab 65 Serostim ® 65 Empatic TM 65 Wafer polifeprosan 65 selective antagonist 65 dacarbazine DTIC 65 LEP ETU 65 alvespimycin 65 octreotide acetate 65 Crofelemer budesonide foam 65 Previously Treated 65 small molecule thrombopoietin 65 Recombinant Human 65 Aflibercept 65 pan histone deacetylase 65 Telik logo TELINTRA 65 Phase 2a Clinical Trial 65 selective modulator 65 small molecule glucokinase 65 Cutaneous T 65 selectively inhibits 65 Double Blind Placebo 65 HGS ETR2 65 demonstrated antitumor activity 65 Humanized Anti 65 Kuvan sapropterin dihydrochloride 65 YONDELIS 65 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 64 Fc fusion protein 64 BENLYSTA TM 64 Talabostat 64 targeting CD# 64 tiapamil 64 TRACON Pharmaceuticals 64 intranasal formulation 64 Lenocta 64 FOLOTYN ® 64 Advanced Renal Cell 64 P#X# antagonist 64 R bendamustine hydrochloride 64 Selective Inhibitor 64 class mGluR5 inhibitor 64 ara C 64 CYP#A# isoenzyme 64 Phase 2b Trial 64 candidate CRLX# 64 Dapagliflozin 64 platform HDL Mimetic 64 forodesine purine nucleoside phosphorylase 64 Pharma Merck Serono 64 ® tiagabine hydrochloride 64 Cloretazine 64 acetonide FA 64 TO AVOID PREGNANCY WHILE 64 phase IIb clinical 64 stable nucleic acid 64 Pafuramidine 64 neutropenia dehydration dyspnea 64 Thiarabine 64 Phase IIa Clinical Trial 64 class oral heparinoid 64 ALN TTR 64 FUSILEV enhances 64 delta opioid receptor 64 NS5B polymerase 64 dual orexin receptor 64 Epothilone D 64 Camptosar ® irinotecan 64 personalized cellular immunotherapy 64 Initiates Phase 64 BCG refractory carcinoma 64 Mg Usa 64 XOMA 3AB 64 Cannabinor 64 Annamycin 64 Fludara ® 64 PGL# 64 Prolongs Survival 64 sorafenib tablets 64 MT#/MEDI-# 64 Luveris R Ovidrel R 64 Methylnaltrexone 64 Xanafide 64 Curaxin CBLC# 64 TRACON Pharmaceuticals Inc. 64 cromolyn sodium 64 topically applied SEPA 64 DNA methyltransferase inhibitors 64 Sapacitabine 64 Luteinizing Hormone Releasing Hormone 64 Refractory Hodgkin Lymphoma 64 VIVITROL ® 64 Systemic Delivery 64 advanced metastatic renal 64 mertansine 64 irreversible inhibitor 64 Bone Augmentation Material 64 Genasense oblimersen sodium Injection 64 candidate AP# 64 thrombin component 64 Vidaza R 64 ERBITUX cetuximab 64 Archexin 64 MKC# 64 By JAMAAL ABDUL 64 recurrent metastatic ovarian cancer 64 novel DACH platinum 64 brivanib 64 XL# XL# XL# XL# 64 evaluating satraplatin 64 small molecule defensin 64 TRANSDUR ® 64 Ostabolin C TM 64 Patients Treated With 64 Files Investigational 64 Phase III Clinical Trial 64 TRANSDUR ™ 64 GW# [003] 64 Receives Milestone Payment 64 investigational monoclonal antibody 64 selective androgen receptor modulator 64 candidates Azedra 64 Vicriviroc 64 sulfonylhydrazine class 64 CDK inhibitor 64 Atripla combines 64 Serdaxin ® 64 Hedgehog Pathway Inhibitor 64 oral proteasome inhibitor 64 aplastic anemia AA 64 Initiates Clinical 64 delivery polymer matrix 64 Nucleoside 64 NDA Submission 64 hypoxia selective 64 generation nucleoside analog 64 Soft Tissue Sarcoma 64 Prodarsan R 64 PROSTASCINT R 64 selective phosphodiesterase 64 Genasense ® 64 cisplatin gemcitabine 64 SPL# Gel vaginal microbicide 64 Complicated Skin 64 OctoPlus licensed 64 Friedreich Ataxia FRDA 64 Zalypsis 64 TNF alpha selectively neutralizing 64 Angiotensin Converting Enzyme 64 Initiates Clinical Trials 64 Initiated Phase 64 JAK2 Inhibitor 64 cis retinoic acid 64 Aganocide 64 iloprost synthetic compound 64 Small Molecule 64 humanized anti 64 #HT# 64 substantially excreted 64 Hematide ™ 64 Vascular Disrupting Agent 64 Metastatic Melanoma 64 Well Tolerated 64 Brentuximab Vedotin SGN 64 HMG CoA reductase inhibitors 64 novel synthetic PEGylated 64 Therapeutic Competitors Companies 64 humanized interleukin 6 64 HCV protease inhibitor 64 TLR9 agonist 64 oral anti arrhythmic 64 Factor VIIa 64 trial evaluating PRX# 64 iobenguane 64 Liposomal 64 PF # [002] 64 irinotecan containing 64 Initiates Phase 2b 64 MT# MEDI 64 long acting muscarinic 64 ELADUR ™ 64 microtubule inhibitor 64 Commence Phase 64 inhibits topoisomerase II 64 thalidomide Thalomid 64 Ozarelix 64 dopamine D2 64 R bortezomib 64 Histone Deacetylase 64 TRIOLEX ™ 64 oral isotype selective HDAC 64 Factor Receptor 64 Protease Inhibitor 64 R sorafenib tablets 64 apricitabine ATC 64 sunitinib Sutent ® 64 plus prednisone prednisolone 64 Immunotherapeutic 63 inflammatory PDE 63 delta gamma agonist 63 KL4 Surfactant 63 COLAZAL R 63 Selective Electrochemical Tumor Ablation 63 polyglutamate 63 DepoCyt ® Abelcet ® 63 CEQ# 63 sitaxsentan 63 oral dual endothelin 63 oxidative stress inducer 63 lenalidomide Revlimid R 63 Testosterone MDTS R 63 selective estrogen receptor modulator 63 Mylan Receives Approval 63 Antigen Specific 63 reversible inhibitors 63 somatostatin analogue 63 Parathyroid Hormone 63 Cathepsin S 63 MEK inhibitor 63 Antiangiogenic 63 huC# DM4 63 Letairis ambrisentan 63 SAR# [004] 63 hypertrichosis occurred 63 GSK# [001] 63 apoptosis proteins 63 Irinotecan 63 Submits Biologics License Application 63 Cloretazine VNP#M 63 Levoleucovorin 63 FEMALES SHOULD BE ADVISED 63 Frozen Shoulder syndrome Adhesive 63 Bosutinib 63 JAK2 inhibitor 63 fludarabine phosphate 63 NU# direct 63 Zenvia TM 63 luteinizing hormone releasing 63 investigational pan BCR 63 inhaled formulation 63 Aeolus Pharmaceuticals Announces 63 leukemia AML 63 NPC 1C 63 Sphingomab TM 63 Amrubicin 63 developing Zerenex TM 63 MGd 63 BiTE R 63 Tyrosine Kinase Inhibitor 63 includes TOLAMBA TM 63 humanized monoclonal 63 Thrombin topical Recombinant 63 interferon beta 1a infertility 63 Hos2 63 bortezomib Velcade R 63 platinum chemotherapeutic 63 diarrhea predominant irritable 63 Antisense Oligonucleotides 63 Ibritumomab Tiuxetan 63 mda 7 63 CD# CEA 63 rHuPH# recombinant human 63 evaluating bafetinib 63 Homspera TM 63 IV FENTORA R 63 markets HP Acthar 63 EGFR expressing mCRC 63 BYETTA ® 63 5 fluorouracil leucovorin 63 PEGylated interferon 63 First Patient Dosed 63 Phase III Trial 63 Isavuconazole 63 GMX# 63 ADP receptor antagonist 63 triciribine phosphate monohydrate 63 Epratuzumab 63 Investigational Compound 63 forodesine 63 Staphylococcus aureus Immune Globulin 63 compound INCB# 63 ferric citrate 63 carcinoid syndrome 63 Sodium oxybate 63 please visit http:/www.vandapharma.com 63 Vitamin D analogue 63 Oral Calcitonin 63 oral Janus kinase 63 lead heptagonist compound 63 non thiazolidinedione TZD 63 cyclin dependent kinase inhibitor 63 Locteron combines 63 DiLA2 63 Antitumor Activity 63 NS5b 63 humanized therapeutic 63 memantine HCl 63 inhibitor PPI 63 ELACYT 63 Darinaparsin 63 include VALSTAR TM 63 Ridaforolimus 63 auristatin 63 markets COLAZAL 63 generation antisense inhibitor 63 ENABLE Phase 2 63 apoptosis inducers 63 estrogen receptor antagonist 63 Protexia ® 63 Cardium Therapeutics TM 63 certain protein tyrosine 63 candidate REP# 63 Successfully Completes Phase 63 CTAP# Capsules 63 TLR7 agonist 63 Nilotinib 63 multi kinase inhibitor 63 Anti Tumor Activity 63 By JENNIFER LEARN 63 Adjuvant Treatment 63 modified glutathione analog 63 TELINTRA 63 Transported Prodrug 63 Custirsen 63 Mg Uk 63 Elesclomol 63 vaccine RiVax TM 63 receiving INTRON 63 CD4 monoclonal antibody 63 pharmacologically active isomer 63 Gonal f R 63 Pruvel ™ prulifloxacin 63 Palifosfamide 63 HCV protease 63 Parkinson disease levodopa induced 63 gemcitabine Gemzar ® 63 rash pruritus nausea 63 Gentamicin Surgical Implant 63 ThermoDox R 63 Kahalalide F 63 autologous cellular immunotherapy 63 Enzyme Replacement Therapy 63 Glufosfamide 63 Surgical Hemostat 63 orally bioavailable mimics 63 FDA APPROVES 63 sodium thiosulfate STS 63 Clinical Trial Results 63 inhibit oxidative stress 63 novel MetAP 2 63 Onco TCS 63 fosbretabulin 63 Teva Provides Update 63 Belimumab 63 interferon alpha IFN 63 Interferon gamma 63 Xcytrin R 63 anticancer compound 63 benzoic acid hyoscyamine sulfate 63 pathophysiological effects 63 MCSP respectively 63 signal transduction inhibitor 63 Elagolix 63 TÎ ² 4 63 Hedgehog pathway inhibitor 63 brand ciclesonide HFA 63 radiation sensitizer 63 ABL inhibitor 63 RESTORE CLI trial 63 candidate ridaforolimus 63 secretory phospholipase A2 63 formerly LymphoStat B 63 Saizen ® 63 Phase Ib clinical trials 63 anti atherothrombotic 63 JAK1 63 refractory cutaneous T 63 Gel repository corticotropin injection 63 Investigational Treatment 63 Solzira ™ 63 E1 INT TM 63 telomerase inhibitor drug 63 Sudhir Agrawal D.Phil 63 Acute Myeloid Leukemia AML 63 GSK '# 63 Pharmos proprietary 63 VentiRx Pharmaceuticals 63 pseudobulbar affect PBA 63 Cetrorelix 63 relapsed acute myelogenous 63 Lymphocytic 63 antimetabolite 63 Phase 2a Trial 63 sulodexide 63 Daclizumab 63 Linaclotide 62 folate analogue metabolic 62 developing ACAPODENE 62 oral beclomethasone dipropionate 62 Demonstrates Significant 62 Cortoss TM 62 Submits IND 62 PROVENGE ® 62 Deforolimus 62 Inc. Nasdaq OXGN 62 prokinetic agent 62 Spectrum Pharmaceuticals Announces 62 MVA BN R 62 corticotropin injection 62 investigational oral hepatitis C 62 antibiotic candidate Ramoplanin 62 Preclinical Data 62 omecamtiv mecarbil formerly 62 rhIGF-I/rhIGFBP-3 62 neuropathic pain metabolic diseases 62 hyperplasia BPH 62 PEGINTRON TM 62 clinical trials Archexin ® 62 Azedra TM 62 transthyretin mediated amyloidosis ATTR 62 Silodosin 62 ALTROPANE R 62 relapsed leukemia 62 Ribavirin causes 62 Solution XOPENEX HFA 62 Submits Response 62 Excellarate TM 62 Perifosine 62 chronic eosinophilic leukemia 62 oral immunomodulatory 62 VNP#M 62 trastuzumab DM1 T DM1 62 human IgG1 monoclonal 62 KSP inhibitor 62 ® decitabine 62 EZN 62 allogeneic epidermal 62 Nitazoxanide 62 Single Dose 62 selective kinase inhibitor 62 CYC# 62 receptor partial agonist 62 systemically administered 62 humanized monoclonal antibody 62 Serostim R 62 chimeric monoclonal antibody 62 demethylating agents 62 proprietary intranasal insulin 62 Nasdaq XTLB 62 ceftazidime 62 CCX# B 62 valtorcitabine 62 Onalta TM 62 Vitro Activity 62 ZFN TM 62 transthyretin TTR mediated amyloidosis 62 AAG KOS 62 Haemophilus b Conjugate 62 ELADUR TM 62 EVIZON TM squalamine lactate 62 ALN TTR# 62 Alocrest 62 Intravesical 62 MVA HPV IL2 62 Hormone Refractory Prostate Cancer 62 systemic juvenile idiopathic 62 Uricase PEG 62 Am J Obstet 62 lanreotide 62 polysaccharide polymer 62 romidepsin novel 62 Inhalation Powder 62 oncolytic virus therapies 62 systemic lupus erythematosus rheumatoid 62 R MSCRAMM 62 Phase Ib IIa 62 EVIZON TM 62 5 HT2A serotonin 62 unresectable locally advanced 62 seliciclib CYC# 62 idiopathic thrombocytopenic purpura ITP 62 Cytarabine 62 compound perifosine 62 sodium Injection 62 RECOTHROM ® 62 potently inhibit 62 symbol AVXL 62 Solulin 62 proprietary polysaccharide 62 Androxal TM 62 nephropathic cystinosis 62 Aztreonam Lysine 62 Diabetic Nephropathy 62 anti secretory 62 BUPHENYL 62 Receptor Agonist 62 OPAXIO TM 62 NASDAQ ENZN 62 PDE4 62 IN PATIENTS WITH 62 label Lipofen R 62 Xyfid TM 62 TRO# 62 ® adefovir dipivoxil 62 proliferator activated receptor 62 peripherally restricted 62 Peginterferon Alfa 2a 62 inhibits dihydrofolate reductase 62 Aplidin R 62 Treatment Naïve 62 immunosuppressive compound 62 urate oxidase 62 Announces Tentative Approval 62 Therapeutic Competitors companiesandmarkets.com adEgemonye 62 selective inhibition 62 Antitumor activity 62 MDRNA proprietary 62 Philadelphia Chromosome Positive 62 Exelixis compounds 62 Onalta ™ 62 selective inverse agonist 62 developed preclinically 62 Cleviprex TM clevidipine 62 mTOR mammalian target 62 Vidaza azacitidine 62 transcriptase inhibitor NNRTI 62 Chemokine Receptor 62 Enrolls First 62 Cerebril TM 62 collagen sponge seeded 62 targets Galectin receptors 62 Intermezzo ® zolpidem tartrate 62 AVE# 62 Protexia R 62 albiglutide 62 small molecule activator 62 gastrointestinal stromal 62 Pharmacokinetics PK 62 Relapsed Refractory 62 novel antimitotic agent 62 forodesine hydrochloride 62 orally inhaled 62 activin receptor type 62 novel peptide 62 Demonstrates Potential 62 Inc. www.micromet inc.com 62 nasal calcitonin product 62 OvaRex R 62 TRX1 62 anthracycline taxane 62 Antithrombin 62 Anti Tumor 62 PrevOnco 62 Azacitidine 62 Lenalidomide 62 AERx ® 62 alkylating 62 tazobactam 62 kidney urologic 62 oxybutynin ATD TM 62 HER1 62 oropharyngeal candidiasis OPC 62 FDA Accepts 62 arsenic trioxide injection GABITRIL 62 ergot derivatives 62 Romiplostim 62 hyaluronidase rHuPH# 62 stage antibody MT# 62 Collaborators Present 62 gastrin analogue TT 62 ACTIQ ® 62 5 lipoxygenase activating 62 tests miRview TM 62 personalized dendritic cell 62 recombinant PSMA vaccine 62 Zevalin R Ibritumomab 62 Angiolix R 62 dihydrofolate reductase 62 peptide conjugated 62 Homspera ® 62 OAB overactive bladder 62 vesicular monoamine transporter 62 histone deacetylase inhibitor 62 OTCBB HXBM developer 62 Paliperidone ER 62 Thalomid ® 62 Onalta 62 Akt inhibitor 62 ARIKACE ™ 62 Spiegelmer ® 62 Valortim TM 62 Dose Ranging Study 62 Myelodysplastic Syndrome MDS 62 Lubiprostone 62 IMA# 62 COPEGUS R 62 GATTEX ™ 62 pyrexia mucositis sepsis febrile 62 R rilonacept Injection 62 novel orally bioavailable 62 Blinatumomab 62 PROVIGIL ® 62 sarcoma melanoma 62 Maxy G# 62 Denufosol 62 overactive bladder AA# 62 RhuDex TM 62 imatinib Gleevec ® 62 Peginterferon 62 HQK 62 Bazedoxifene 62 Ambrisentan 62 Randomized Double Blind 62 ARCALYST R 62 Elvitegravir 62 Fulvestrant 62 beta 1a 62 auristatin E MMAE 62 Asentar TM 62 Matrix Phase 2b 62 Pooled Analysis 62 OvaRex ® MAb 62 Sciences ABthrax Albuferon 62 generation antisense 62 CTA# Injection 62 abacavir sulfate lamivudine 62 Initiate Clinical Trial 62 Nexavar ® 62 metastatic hormone refractory 62 small molecule tyrosine 61 IMC #B 61 elotuzumab 61 CysDisplay R 61 midstage clinical 61 evaluating T DM1 61 5 HT6 receptor 61 ABLYNX 61 Locked Nucleic Acid 61 plus Copegus R 61 Besivance 61 generation geldanamycin analog 61 RhuDex ® 61 developing ostarine selective 61 modafinil Tablets C 61 J Am Acad 61 BRILINTA 61 soluble tumor necrosis 61 Marqibo TM 61 Demonstrates Efficacy 61 XL# XL# XL# 61 perifosine KRX 61 Corp. AMEX CVM 61 Polymerase Inhibitor 61 ovarian esophageal 61 Traficet EN 61 HGS ETR1 61 HCD# [002] 61 ENTB 61 www.antigenexpress.com 61 phase Ib clinical 61 Myelofibrosis 61 Systemic lupus erythematosus 61 Submits Supplemental 61 Dalbavancin 61 Long acting beta2 61 rasagiline tablets 61 cyclobenzaprine hydrochloride extended 61 Therapeutic Vaccine 61 including cyclosporine methotrexate 61 samarium Sm 61 non splenectomized 61 Bafetinib 61 Carcinoid tumors 61 vitreoretinal disorders 61 anti CD3 monoclonal